Product details |
Supply Impact Dates |
Further Details |
CONCERTA methylphenidate hydrochloride 18mg modified release tablet bottle AUST R: 93862Active ingredients:
methylphenidate hydrochloride
Dosage form: Tablet, modified release
Sponsor: Janssen-Cilag Pty Ltd
Phone: 1800226334
|
From 29 Oct 2024 to 31 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Manufacturing
Management action: Patients are advised to consult their healthcare professional to discuss their options.Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products.
|
CONCERTA methylphenidate hydrochloride 27mg modified release tablet bottle AUST R: 124502Active ingredients:
methylphenidate hydrochloride
Dosage form: Tablet, modified release
Sponsor: Janssen-Cilag Pty Ltd
Phone: 1800226334
|
From 19 Dec 2024 to 31 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Manufacturing
Management action: Patients are advised to consult their healthcare professional to discuss their options.Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products.
|
CONCERTA methylphenidate hydrochloride 36mg modified release tablet bottle AUST R: 93863Active ingredients:
methylphenidate hydrochloride
Dosage form: Tablet, modified release
Sponsor: Janssen-Cilag Pty Ltd
Phone: 1800226334
|
From 16 Dec 2024 to 31 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Manufacturing
Management action: Patients are advised to consult their healthcare professional to discuss their options.Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products.
|
CONCERTA methylphenidate hydrochloride 54mg modified release tablet bottle AUST R: 93864Active ingredients:
methylphenidate hydrochloride
Dosage form: Tablet, modified release
Sponsor: Janssen-Cilag Pty Ltd
Phone: 1800226334
|
From 16 Oct 2024 to 31 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Manufacturing
Management action: Patients are advised to consult their healthcare professional to discuss their options.Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 18 mg modified release tablet bottle AUST R: 370912Active ingredients:
methylphenidate hydrochloride
Dosage form: Tablet, modified release
Sponsor: Teva Pharma Australia Pty Ltd
Phone: 1800 288 382
|
From 04 Sep 2024 to 31 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Unexpected increase in demand due to other sponsors unable to supply
Management action: Patients are advised to consult their healthcare professional to discuss their options.Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products.
|
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 27 mg modified release tablet bottle AUST R: 370911Active ingredients:
methylphenidate hydrochloride
Dosage form: Tablet, modified release
Sponsor: Teva Pharma Australia Pty Ltd
Phone: 1800 288 382
|
From 14 Jan 2025 to 31 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Unexpected increase in demand due to other sponsors unable to supply
Management action: Patients are advised to consult their healthcare professional to discuss their options.Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products.
|
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 36 mg modified release tablet bottle AUST R: 370900Active ingredients:
methylphenidate hydrochloride
Dosage form: Tablet, modified release
Sponsor: Teva Pharma Australia Pty Ltd
Phone: 1800 288 382
|
From 14 Jan 2025 to 31 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Unexpected increase in demand due to other sponsors unable to supply
Management action: Patients are advised to consult their healthcare professional to discuss their options.Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 54 mg modified release tablet bottle AUST R: 370899Active ingredients:
methylphenidate hydrochloride
Dosage form: Tablet, modified release
Sponsor: Teva Pharma Australia Pty Ltd
Phone: 1800 288 382
|
From 30 Sep 2024 to 31 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Unexpected increase in demand due to other sponsors unable to supply
Management action: Patients are advised to consult their healthcare professional to discuss their options.Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products.
|
RITALIN LA methylphenidate hydrochloride 10 mg modified release capsule bottle AUST R: 160228Active ingredients:
methylphenidate hydrochloride
Dosage form: Capsule, modified release
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Phone: 0298053555
|
From 24 Apr 2025 to 31 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Manufacturing
Management action: Patients are advised to consult their healthcare professional to discuss their options.Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
RITALIN LA methylphenidate hydrochloride 30mg modified release capsule bottle AUST R: 82958Active ingredients:
methylphenidate hydrochloride
Dosage form: Capsule, modified release
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Phone: 0298053555
|
From 11 Jun 2025 to 31 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Manufacturing
Management action: Patients are advised to consult their healthcare professional to discuss their options.Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
RITALIN LA methylphenidate hydrochloride 40mg modified release capsule bottle AUST R: 82959Active ingredients:
methylphenidate hydrochloride
Dosage form: Capsule, modified release
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Phone: 0298053555
|
From 29 Apr 2025 to 31 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Manufacturing
Management action: Patients are advised to consult their healthcare professional to discuss their options. Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
RITALIN LA methylphenidate hydrochloride 60mg modified release capsules bottle AUST R: 236251Active ingredients:
methylphenidate hydrochloride
Dosage form: Capsule, modified release
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Phone: 0298053555
|
From 01 May 2025 to 31 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Manufacturing
Management action: Patients are advised to consult their healthcare professional to discuss their options.Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
RUBIFEN LA methylphenidate hydrochloride 10 mg modified release capsules blister pack AUST R: 362233Active ingredients:
methylphenidate hydrochloride
Dosage form: Capsule, hard
Sponsor: AFT Pharmaceuticals Pty Ltd
Phone: 02 94200420
|
From 03 Jun 2025 to 15 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Unexpected increase in demand due to other sponsors unable to supply
Management action: Patients are advised to consult their healthcare professional to discuss their options.Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
RUBIFEN LA methylphenidate hydrochloride 30 mg modified release capsules blister pack AUST R: 362232Active ingredients:
methylphenidate hydrochloride
Dosage form: Capsule, hard
Sponsor: AFT Pharmaceuticals Pty Ltd
Phone: 02 94200420
|
From 10 Jun 2025 to 15 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Unexpected increase in demand due to other sponsors unable to supply
Management action: Patients are advised to consult their healthcare professional to discuss their options.Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
RUBIFEN LA methylphenidate hydrochloride 40 mg modified release capsules blister pack AUST R: 362230Active ingredients:
methylphenidate hydrochloride
Dosage form: Capsule, hard
Sponsor: AFT Pharmaceuticals Pty Ltd
Phone: 02 94200420
|
From 13 May 2025 to 15 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Unexpected increase in demand due to other sponsors unable to supply
Management action: Patients are advised to consult their healthcare professional to discuss their options. Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
RUBIFEN LA methylphenidate hydrochloride 60 mg modified release capsules blister pack AUST R: 362234Active ingredients:
methylphenidate hydrochloride
Dosage form: Capsule, hard
Sponsor: AFT Pharmaceuticals Pty Ltd
Phone: 02 94200420
|
From 18 Apr 2025 to 15 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Unexpected increase in demand due to other sponsors unable to supply
Management action: Patients are advised to consult their healthcare professional to discuss their options.Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
RITALIN 10 methylphenidate hydrochloride 10mg tablet blister pack AUST R: 11052Active ingredients:
methylphenidate hydrochloride
Dosage form: Tablet, uncoated
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Phone: 0298053555
|
From 25 Aug 2025 to 31 Oct 2025
|
Shortage status: Anticipated
Availability: Available
Reason: Manufacturing
Management action: The sponsor is working to expedite the next shipment. An alternative brand is available.
|
RITALIN LA methylphenidate hydrochloride 20mg modified release capsule bottle AUST R: 82957Active ingredients:
methylphenidate hydrochloride
Dosage form: Capsule, modified release
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Phone: 0298053555
|
From 22 Jul 2025 to 31 Dec 2025
|
Shortage status: Anticipated
Availability: Available
Reason: Manufacturing
Management action: Patients are advised to consult their healthcare professional to discuss their options.Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
RUBIFEN LA methylphenidate hydrochloride 20 mg modified release capsules blister pack AUST R: 362231Active ingredients:
methylphenidate hydrochloride
Dosage form: Capsule, hard
Sponsor: AFT Pharmaceuticals Pty Ltd
Phone: 02 94200420
|
From 31 Jul 2025 to 15 Dec 2025
|
Shortage status: Anticipated
Availability: Available
Reason: Unexpected increase in demand due to other sponsors unable to supply
Management action: Patients are advised to consult their healthcare professional to discuss their options.Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
ARTIGE methylphenidate hydrochloride 10mg tablet blister pack AUST R: 117306Active ingredients:
methylphenidate hydrochloride
Dosage form: Tablet, uncoated
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Phone: 0298053555
|
From 07 Apr 2025 to 15 Apr 2025
|
Shortage status: Resolved
Availability: Available
Reason: Transport / Logistic issues / Storage capacity issues
|
METHYLPHENIDATE XR ARX methylphenidate hydrochloride 27 mg modified release tablet bottle AUST R: 344270Active ingredients:
methylphenidate hydrochloride
Dosage form: Tablet, modified release
Sponsor: Teva Pharma Australia Pty Ltd
Phone: 1800 195 055
|
Deletion from market:
31 Jul 2024
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Manufacturing
Management action: Alternative generic products are available.
|
METHYLPHENIDATE XR ARX methylphenidate hydrochloride 36 mg modified release tablet bottle AUST R: 344277Active ingredients:
methylphenidate hydrochloride
Dosage form: Tablet, modified release
Sponsor: Teva Pharma Australia Pty Ltd
Phone: 1800 195 055
|
Deletion from market:
31 Jul 2024
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Manufacturing
Management action: An alternative generic product is available.
|
METHYLPHENIDATE XR ARX methylphenidate hydrochloride 54 mg modified release tablet bottle AUST R: 344275Active ingredients:
methylphenidate hydrochloride
Dosage form: Tablet, modified release
Sponsor: Teva Pharma Australia Pty Ltd
Phone: 1800 195 055
|
Deletion from market:
31 Jul 2024
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Manufacturing
Management action: The sponsor is closely monitoring the supply.Patients are advised to consult their healthcare professional to discuss their options. An unregistered product has been approved for supply under Section 19A. The approval holder, Medsurge Healthcare Pty Ltd can be contacted for details on supply on 1300 788 261.
|